Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Dec 7, 2017 (9 years ago)

Ephedrine sulfate 5 mg/mL in 0.9% Sodium Chloride 10 mL in Single Dose Syringe

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Labeling: Incorrect or Missing Lot and/or Exp Date - product label was missing lot number and beyond use date.

Cause type: Labeling / mix-up

Wrong label, wrong strength, mixed-up products, or packaging errors. One of the most dangerous causes - you can end up taking the wrong drug or the wrong dose. All labeling / mix-up recalls.

What was recalled

Ephedrine sulfate 5 mg/mL in 0.9% Sodium Chloride 10 mL in Single Dose Syringe, Total Volume 10 mL, Rx only, SCA Pharmaceuticals, 8821 Knoedl Ct. Little Rock, AR 72205, NDC 70004-0600-12

Affected NDC 70004-0600-12

Compare with the code on your package — it is the most precise check available.

Drug: Ephedrine

Recalling firm
SCA Pharmaceuticals
NDC code
70004-0600-12
Origin
AR, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0156-2018 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Ephedrine recalls

See all
Class II · Moderate risk

Ephedrine Plus

cGMP deviations

Terminated cGMP deviation Ultra Seal Corporation NDC 65193-320-24 D-0473-2022

Other recalls by SCA Pharmaceuticals

All 2017 recalls